A Smart + Strong Site
Subscribe to:
Newsletters
POZ magazine
JOIN AIDSMEDS YouTube

Back to home » Treatment News » Top Stories


April 24, 2015
Women in Failed PrEP Trial Lied About Pill Use to Stay In Study
Female participants in a failed study of Truvada as pre-exposure prophylaxis (PrEP) often lied about their pill use in order to remain in the study.
April 23, 2015
ARVs Cut HIV Transmission Risk By 67% in Chinese Real-World Study
A Chinese study of the real-world effects of antiretroviral treatment's capacity to reduce the risk of HIV transmission has found it halves the risk, and in more recent years treatment led to a two-thirds risk reduction.
April 22, 2015
HIV Ages Immune Cell DNA by 14 Years
Untreated HIV causes changes to cellular DNA that are akin to 14 years of aging, which may partially explain the early onset of age-related diseases among people living with the virus.
European Liver Group Issues New Hep C Treatment Guidelines
The European Association for the Study of the Liver has issued revised guidelines for the treatment of hepatitis C.
April 21, 2015
HIV Researcher Questions Prevailing Wisdom About the Virus
A major HIV researcher has challenged colleagues to question various perceptions about the virus and its treatment in hopes of spurring new research channels.
April 20, 2015
Good Mental Health Likely Means Good Adherence to HIV Meds
Psychological wellbeing emerged as the only factor that predicted good adherence to HIV antiretrovirals in a recent study.
April 17, 2015
HIV Antibody Infusion Shows Promise in Treating The Virus
A single infusion of a broadly neutralizing HIV antibody has reduced viral loads for up to four weeks among HIV-positive individuals.
April 16, 2015
Intervention Improves HIV Med Adherence Among Blacks and Latinos
A counseling-based intervention has succeeded in improving adherence to antiretrovirals among HIV-positive blacks and Latinos who are reluctant to start treatment.
April 15, 2015
Poll of HIV Providers Finds Some Reluctance Toward PrEP Prescribing
A poll of HIV specialists has found evidence of less than full-fledged enthusiasm with regards to prescribing PrEP, depending on the patient group.
April 14, 2015
Statins May Cut Heart Disease Risk in HIV-Positive People
Research increasingly suggests that statins can prevent the advancement of coronary atherosclerosis among HIV-positive people.
April 13, 2015
Program Succeeds at Better Keeping People With HIV in Medical Care
A program designed to rate the rate of HIV-positive people who stay in routine medical care has succeeded, and at a cost deemed reasonable.
April 10, 2015
NIH Funds Research Into 'Kick and Kill' HIV Cure Strategy
The National Institutes of Health has pledged $6.6 million to support the first human clinical trial into a cure strategy known as “kick and kill.”
April 09, 2015
HIV Treatment Guidelines Nix Atripla as First-Line Therapy
A revision of U.S. HIV treatment guidelines has removed Atripla (efavirenz/tenofovir/emtricitabine) from the priority list of first-line antiretrovirals.
April 08, 2015
Gilead Applies for FDA Approval of New Version of Truvada
Gilead Sciences has filed for FDA approval of a new version of the dual-combination HIV antiretroviral Truvada that is less toxic to the bones and kidneys.
April 07, 2015
Early HIV Replication in the Brain Supports Hasty Treatment Start
HIV can replicate and evolve in the brain soon after infection, according to a recent analysis of cerebral spinal fluid, which helps illuminate such activity in the brain.
April 06, 2015
Kids Who Start HIV Treatment With Low CD4s Largely Regain Them
HIV-positive children who have low CD4 counts when starting treatment by and large experience a rebound to normal levels of those immune cells.
April 03, 2015
Effective Two-Drug HIV Regimen Sets Stage for Long-Acting Treatment
For those with fully suppressed HIV, switching to a two-drug regimen of cabotegravir and Edurant (rilpivirine) works as well taking a triple regimen based on Sustiva (efavirenz).
April 02, 2015
No Matter How You Slice It, PrEP Rollout Should Save Money
Canadian research suggests that rolling out Truvada as PrEP to prevent HIV would save money even if the cost to treat the virus drops in the future.
April 01, 2015
Risk Factors for Hep C Acquisition Among HIV-Positive Gay Men
Condomless receptive intercourse, ulcerative STIs, fisting and sharing sex toys are all linked with  acquiring hepatitis C among HIV-positive gay men.
Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
 
Archive

April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
February 2006
October 2005

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter


Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014


21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014


7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.